There is also some evidence that treatment-resistant depression (TRD) is characterized by specific immune biomarkers, including increased IL-6, sIL-1RA, and TNFα concentrations (Maes et al. 1997; Lanquillon et al. 2000). Here, IL6 is linked to treatment resistant depression.